RxDoctor Payments DataLook up a doctor →

Jonathan Hodgson, DO

Neurology · Gilbert, AZNPI 1851345433

Payments from drug & device makers

$1,771,184in general payments, 2019–2025

Across 2,334 payments — averaging $758.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$818K
  • AbbVie$332K
  • E.r. Squibb & Sons, L.L.C.$167K
  • Lilly USA, LLC$143K
  • Sage Therapeutics, LLC$126K
  • Eisai Inc.$84K
  • plus $101K from 54 others
$19,435in research payments, 2019–2025

Across 7 payments — averaging $2776.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$19K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly23$817,688
AbbVie(2 entities)523$331,565
E.r. Squibb & Sons, L.L.C.7$166,922
Lilly USA, LLC346$143,046
Sage Therapeutics, LLC3$125,992
Eisai Inc.187$84,268
H. Lundbeck A S6$24,248
Biohaven Pharmaceuticals, Inc.32$18,369
Lundbeck LLC59$17,725
Biohaven Pharmaceutical Holding Company Ltd.40$13,292
Biogen60$8,114
Amgen(2 entities)81$1,924
Genentech, Inc.1$1,335
UCB, Inc.85$1,210
Pfizer61$1,138
Novartis67$1,116
Sanofi42$1,082
CSL Behring29$862
Teva Pharmaceuticals USA, Inc.44$805
Upsher-smith Laboratories LLC67$769
EMD Serono, Inc.40$652
Neurocrine Biosciences, Inc.31$565
Argenx US, Inc.16$492
Amneal Pharmaceuticals LLC26$452
AstraZeneca(2 entities)21$397
Genentech USA, Inc.17$383
Otsuka America Pharmaceutical, Inc.28$362
Acadia Pharmaceuticals Inc19$361
Banner Life Sciences, LLC26$359
Impel Pharmaceuticals Inc.18$303
SK Life Science, Inc.14$295
Avanir Pharmaceuticals, Inc.34$292
Bristol Myers Squibb15$269
Medtronic(2 entities)14$263
Merz Pharmaceuticals, LLC9$250
MDD US Operations, LLC10$246
Avion Pharmaceuticals12$221
TG Therapeutics, Inc.7$196
Zyla Life Sciences, Inc.31$193
Grifols USA, LLC10$189
Kyowa Kirin, Inc.9$177
Acorda Therapeutics, Inc8$167
Assertio Therapeutics, Inc.17$149
Corium, LLC12$147
Merz North America, Inc.6$146
Abbott6$136
Mallinckrodt Enterprises LLC7$124
Jazz Pharmaceuticals Inc.6$94
Johnson & Johnson6$92
Neurelis, Inc.5$90
Mallinckrodt Hospital Products Inc.4$84
Supernus Pharmaceuticals, Inc.5$81
ANI Pharmaceuticals, Inc.4$76
Alnylam Pharmaceuticals Inc.4$76
Catalyst Pharmaceuticals, Inc.4$65
Livanova USA, Inc.4$65
Boston Scientific3$61
Currax Pharmaceuticals LLC4$56
Insightec,inc2$50
Merck4$50

How this compares

$1,771,184 in reported general payments places this provider in the 95th percentile of 388 neurology providers in Arizona.

See all neurology providers in Arizona

Medicare billing

Part B allowed, 2024
$475,592
Medicare patients
920
Services billed
28,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →